Well, I can understand asking tough questions and keeping
Well, I can understand asking tough questions and keeping on top of what is going on with your investment, but at some point you have to also step back and realize that the answers may not come as fast as we would like or even expect. I believe If Leo had anything to report, it would be reported plain and simple as it always has been.
Dana Farber is doing what needs to be done and keeping the trial running smoothly 6months in now. I am fine with patiently waiting to hear info when they decide to share it, its their show.
Leo is as anxious as we are for results, but you hit a point of saturation with PRs when there is no new data to report. So until we do get something new, it is simply a waiting game. I am fine with that, but I understand that some are anxious for answers, unfortunately the reality here is it is out of Leo's capable hands and in the hands of Dr Shapiro and his team at DF. I am sure he is much more concerned with a flawless trial running up to ASCO, and not how soon he shares more with leo so we can get a PR.
This is where long term holders are tested, and where we "earn" our right to capture the massive profits that will be coming shortly down the road.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Top 5 Most Recently Viewed Articles
CoreWeave Stock Surges with NVIDIA Agreement Shares of CoreWeave, Inc. experienced a notable increase recently following the announcement of a significant partnership with NVIDIA Corp. This new agreement, valued at an initial $6.3 billion, allows NVIDIA to purchase any excess cloud computing capacity that CoreWeave may have available. The partnership is expected to last...
Continue Reading
Coty Inc. Preliminary Q1 Overview Coty Inc. (NYSE: COTY) has recently reported its preliminary numbers for the first quarter, revealing some intriguing insights into its sales growth. The company experienced a modest increase of approximately 4%-5% on a like-for-like basis, which unfortunately fell short of their previous estimate of 6%. This slight underperformance has...
Continue Reading
Introducing Soul Bounce Texture Defining Mousse Uncle Funky's Daughter, a celebrated minority-owned hair care brand, has introduced an innovative product known as Soul Bounce Texture Defining Mousse. This exciting addition aims to elevate the hairstyling routine for individuals with textured hair, offering a solution that balances definition, volume, and health. The...
Continue Reading
Arconic Corporation's Legal Challenges for Investors In the ever-evolving landscape of corporate governance, Arconic Corporation is currently facing serious legal scrutiny. Investors are being made aware that a class action lawsuit has been initiated against the company, highlighting concerns over significant losses among shareholders. Class Action Overview This lawsuit...
Continue Reading
Understanding the Centene Corporation Class Action Lawsuit In recent developments, Centene Corporation (NYSE: CNC) has found itself at the center of a class action lawsuit. This legal proceeding has garnered attention due to allegations that Centene and its senior executives may have violated federal securities laws. Legal representation is being offered by a leading firm...
Continue Reading